BioSpace News Archive

Deals

BioCryst Commences Public Offering of Common Stock - Nov. 12, 2019

BioCryst Pharmaceuticals, Inc. announced that it is offering to sell $55 million of its common stock in an underwritten public offering.

November 12, 2019
·
3 min read
Business

Halozyme Reports Third Quarter 2019 Results

Total Revenues Increase 81% to $46.2 million Compared to $25.6 million in Prior-year Period

November 12, 2019
·
10 min read
Biotech Beach

Neurocrine Biosciences Publishes Long-Term INGREZZA® (valbenazine) Data in the Journal of Clinical Psychopharmacology Demonstrating Once-Daily 40 mg and 80 mg Capsules Reduced Involuntary Movements in Adults with Tardive Dyskinesia

Approximately 90% of Patients Treated with INGREZZA in the Open-Label KINECT 4 Phase III Study Achieved a 50% or Greater Improvement in Their Tardive Dyskinesia Symptoms

November 12, 2019
·
9 min read
Alkermes’ Corporate Presentation to be Webcast at Upcoming Healthcare Conferences on Nov. 19, 2019

Alkermes plc announced that its corporate presentation will be webcast live at the Stifel 2019 Healthcare Conference on Tuesday, Nov. 19, 2019 at 1:15 p.m. ET from New York.

November 12, 2019
·
1 min read
Business

Marker Therapeutics Reports Third Quarter 2019 Operating and Financial Results

Marker Therapeutics, Inc. provided a corporate update and reported financial results for the third quarter ended September 30, 2019.

November 12, 2019
·
7 min read
Business

Cumberland Pharmaceuticals Reports 22% Revenue Growth In The Third Quarter

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology announced third quarter 2019 financial results with net revenues of $10.4 million, up 22% over the prior year quarter.

November 12, 2019
·
19 min read
Job Trends

Savara to Present at the Stifel 2019 Healthcare Conference

Savara Inc., an orphan lung disease company, will be presenting at the Stifel 2019 Healthcare Conference on Tuesday, November 19, 2019 at 3:00 PM ET / 12:00 PM PT at the Lotte New York Palace Hotel.

November 12, 2019
·
1 min read
Business

Regulus Therapeutics Reports Third Quarter 2019 Financial Results and Recent Updates

Receipt of Final Reports from the Chronic Toxicity Studies for Submission of Complete Response to Reinitiate the Multiple Ascending Dose Clinical Study for RGLS4326

November 12, 2019
·
9 min read
Business

Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2019

Varex Imaging Corporation announced its unaudited financial results for the fourth quarter and fiscal year 2019.

November 12, 2019
·
11 min read
Business

Senseonics Holdings, Inc. Reports Third Quarter 2019 Financial Results

Senseonics Holdings, Inc. reported financial results for the quarter ended September 30, 2019.

November 12, 2019
·
8 min read